Granahan Investment Management, LLC Caribou Biosciences, Inc. Transaction History

Granahan Investment Management, LLC

  • $2.38 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$4.82 - $8.26 $313,965 - $538,039
-65,138 Reduced 47.09%
73,192 $376,000
Q4 2023

Feb 14, 2024
BUY
$3.58 - $6.25 $6,988 - $12,200
1,952 Added 1.43%
138,330 $792,000
Q3 2023

Nov 14, 2023
BUY
$4.08 - $8.14 $41,130 - $82,059
10,081 Added 7.98%
136,378 $651,000
Q2 2023

Aug 14, 2023
BUY
$4.04 - $5.47 $18,773 - $25,419
4,647 Added 3.82%
126,297 $536,000
Q1 2023

May 15, 2023
SELL
$4.3 - $7.78 $467,371 - $845,615
-108,691 Reduced 47.19%
121,650 $645,000
Q4 2022

Feb 14, 2023
SELL
$5.57 - $11.01 $43,796 - $86,571
-7,863 Reduced 3.3%
230,341 $1.45 Million
Q3 2022

Nov 14, 2022
SELL
$5.34 - $12.79 $1.13 Million - $2.7 Million
-210,851 Reduced 46.95%
238,204 $2.51 Million
Q2 2022

Aug 15, 2022
BUY
$5.1 - $9.74 $828,153 - $1.58 Million
162,383 Added 56.64%
449,055 $2.44 Million
Q1 2022

May 16, 2022
BUY
$8.42 - $15.32 $1.72 Million - $3.13 Million
204,545 Added 249.06%
286,672 $2.63 Million
Q4 2021

Feb 14, 2022
SELL
$14.59 - $23.26 $872,832 - $1.39 Million
-59,824 Reduced 42.14%
82,127 $1.24 Million
Q3 2021

Nov 15, 2021
BUY
$15.75 - $30.29 $2.24 Million - $4.3 Million
141,951 New
141,951 $3.39 Million

Others Institutions Holding CRBU

# of Institutions
135
Shares Held
52.6M
Call Options Held
148K
Put Options Held
70.7K
View Full List

About Caribou Biosciences, Inc.

CRBU Quotes by TradingView
  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $123M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email